David Raben, Chief Medical Officer: Bicara Therapeutics BCAX Sell · Filed 03/26

Trade details

Type: Insider sale
Amount: $104,225
Shares · price: 5,500 sh · $18.95 a share
Held after: 55,286 sh
Stock: Bicara Therapeutics BCAX
Person: David RabenChief Medical Officer
Trade date: 26/03/25
Filed: 26/03/26
Days to filing: 1 days

Sold 9.0% of holdings

Share of holding sold: 9.0%

Bicara Therapeutics trades, last 26 weeks

What else happened in Bicara Therapeutics around then

Filed or reported within 30 days of the trade day · 02/23~04/24

David Raben's recent trades

David RabenChief Medical Officer
Planned saleBicara Therapeutics
Planned sale
Bicara Therapeutics
BCAX
$1.4M
50,000 sh
$1.4M
Filed 07/08
Traded 07/08
David RabenChief Medical Officer
Planned saleBicara Therapeutics
Planned sale
Bicara Therapeutics
BCAX
$1.3M
50,000 sh
$1.3M
Filed 06/25
Traded 06/25
David RabenChief Medical Officer
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$120K
5,500 sh
$120K
Filed 05/26
Traded 05/26
David RabenChief Medical Officer
Sell10b5-1 planBicara Therapeutics
Sell10b5-1 plan
Bicara Therapeutics
BCAX
$125.8K
5,500 sh
$125.8K
Filed 04/28
Traded 04/27
David RabenChief Medical Officer
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$125.8K
5,500 sh
$125.8K
Filed 04/27
Traded 04/27